NDC 46287-035

NORLIQVA

Amlodipine

NORLIQVA is a Oral Solution in the Human Prescription Drug category. It is labeled and distributed by Cmp Pharma, Inc.. The primary component is Amlodipine.

Product ID46287-035_63a6bb49-fb68-4351-be5f-a6b6e8f6b540
NDC46287-035
Product TypeHuman Prescription Drug
Proprietary NameNORLIQVA
Generic NameAmlodipine
Dosage FormSolution
Route of AdministrationORAL
Marketing Start Date2022-04-15
Marketing CategoryNDA /
Application NumberNDA214439
Labeler NameCMP Pharma, Inc.
Substance NameAMLODIPINE
Active Ingredient Strength1 mg/mL
Pharm ClassesCalcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 46287-035-15

150 mL in 1 BOTTLE (46287-035-15)
Marketing Start Date2022-04-15
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "NORLIQVA" or generic name "Amlodipine"

NDCBrand NameGeneric Name
46287-035NORLIQVAamlodipine
33342-015AmlodipineAmlodipine
33342-016AmlodipineAmlodipine
0615-6582Amlodipine BesylateAmlodipine
52652-5001KaterziaAmlodipine

Trademark Results [NORLIQVA]

Mark Image

Registration | Serial
Company
Trademark
Application Date
NORLIQVA
NORLIQVA
90522907 not registered Live/Pending
CMP Development LLC
2021-02-10

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.